Phase IIIB Subcutaneous Abatacept Monotherapy Study
Public ClinicalTrials.gov record NCT00547521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIb, Multi-center, Stratified, Open-Label Study to Evaluate the Immunogenicity, Steady State Trough Level, and Safety of Subcutaneous Abatacept (BMS-188667) in Subjects With Rheumatoid Arthritis Administered With or Without Background Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate safety and immunogenicity of abatacept when used with or without methotrexate in the absence of an IV loading dose of abatacept
Study identification
- NCT ID
- NCT00547521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2007 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- Mar 23, 2015
2007 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates Of North Alabama | Huntsville | Alabama | 35801 | — |
| Coastal Clinical Research Inc | Mobile | Alabama | 36608 | — |
| Stanford University School Of Medicine | Palo Alto | California | 94304 | — |
| Boulder Medical Center | Boulder | Colorado | 80304 | — |
| The Arthritis Center | Palm Harbor | Florida | 34684 | — |
| Medical Towers South | Louisville | Kentucky | 40298 | — |
| Westroads Medical Group | Omaha | Nebraska | 68114 | — |
| Regional Rheumatology Associates | Binghamton | New York | 13905 | — |
| Physicians East, Pa | Greenville | North Carolina | 27834 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
| East Penn Rheumatology Associates | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Low Country Rheumatology, Pa | Charleston | South Carolina | 29406 | — |
| Columbia Arthritis Center | Columbia | South Carolina | 29204 | — |
| Rheumatic Disease Center | Glendale | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00547521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00547521 live on ClinicalTrials.gov.